Patents by Inventor Shuang CAO
Shuang CAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250012846Abstract: A method for testing the total dose effect of a SiC MOSFET device, realizing verification of the complex total dose effect of the SiC MOSFET. The test steps sequentially comprise: testing a tested device before irradiation; performing annealing treatment on the tested device before irradiation; performing an irradiation test on the tested device; performing annealing treatment on the tested device after irradiation; performing test data analysis and processing on the tested device after irradiation. In the test process, threshold voltage shift caused by total dose radiation-induced defects and threshold voltage shift caused by near interface trap charges inherent near a SiC MOSFET interface are measured respectively, comprehensive analysis and calculation are carried out on the test result, the total dose effect resistance capability of the SiC MOSFET device can be given, and a certain guiding effect on device reinforcement is achieved.Type: ApplicationFiled: November 4, 2022Publication date: January 9, 2025Applicant: CHINA ACADEMY OF SPACE TECHNOLOGYInventors: Qingkui YU, He WANG, Shuang CAO, Yi SUN, Bo MEI, He LV, Rigen MO, Qianyuan WANG, Jiajia SUN, Hongwei ZHANG
-
Patent number: 12127856Abstract: The present disclosure relates to a difficult airway evaluation method and device based on a machine learning voice technology. The method includes the following steps: acquiring voice data of a patient; carrying out feature extraction on the voice data, obtaining a pitch period of pronunciations, and acquiring a voiced sound feature and unvoiced sound features based on the pitch period of pronunciations; and constructing a difficult airway evaluation classifier based on the machine learning voice technology, analyzing the received voiced sound feature and unvoiced sound features by the trained difficult airway evaluation classifier, and carrying out scoring on the severity of a difficult airway to obtain an evaluation result of the difficult airway.Type: GrantFiled: July 7, 2022Date of Patent: October 29, 2024Assignee: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of MedicineInventors: Hong Jiang, Ming Xia, Ren Zhou, Shuang Cao, Tian Yi Xu, Jie Wang, Chen Yu Jin, Bei Pei
-
Publication number: 20240037219Abstract: Trusted execution environment construction is described and includes obtaining regulatory requirement information of a trusted execution environment. The regulatory requirement information is parsed to obtain atomized security function information applied to the trusted execution environment. Formal parsing processing is performed on the security function information to obtain a security solution of the trusted execution environment to prove that it satisfies the regulatory requirement information and generating a test case corresponding to the security solution based on an axiom of the security solution. Using a predetermined property migration mechanism based on the security solution and the test case corresponding to the security solution, a trusted execution environment is constructed that has same property information as the security solution and the test case with respect to a predetermined property item in a target scenario.Type: ApplicationFiled: October 6, 2023Publication date: February 1, 2024Applicant: Alipay (Hangzhou) Information Technology Co., Ltd.Inventor: Shuang Cao
-
Publication number: 20230044289Abstract: The present disclosure relates to a difficult airway evaluation method and device based on a machine learning voice technology. The method includes the following steps: acquiring voice data of a patient; carrying out feature extraction on the voice data, obtaining a pitch period of pronunciations, and acquiring a voiced sound feature and unvoiced sound features based on the pitch period of pronunciations; and constructing a difficult airway evaluation classifier based on the machine learning voice technology, analyzing the received voiced sound feature and unvoiced sound features by the trained difficult airway evaluation classifier, and carrying out scoring on the severity of a difficult airway to obtain an evaluation result of the difficult airway.Type: ApplicationFiled: July 7, 2022Publication date: February 9, 2023Applicant: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of MedicineInventors: Hong Jiang, Ming Xia, Ren Zhou, Shuang Cao, Tian Yi Xu, Jie Wang, Chen Yu Jin, Bei Pei
-
Publication number: 20220301717Abstract: The disclosure relates to an artificial intelligence-based difficult airway evaluation method and device. The method includes the following steps: acquiring facial images of various postures; constructing a feature extraction network based on facial recognition, and extracting feature information of the facial images through the trained feature extraction network; and constructing a difficult airway classifier based on a machine learning algorithm, and performing difficult airway severity scoring on the extracted feature information of the facial images through the trained difficult airway classifier to obtain an evaluation result of a difficult airway. According to the present disclosure, early warning can be accurately provided for difficult airways in clinical anesthesia.Type: ApplicationFiled: March 18, 2022Publication date: September 22, 2022Applicant: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of MedicineInventors: Ming Xia, Hong Jiang, Zhi Liang Lin, Yao Kun Zheng, Jie Wang, Ren Zhou, Tian Yi Xu, Shuang Cao
-
Patent number: 11180463Abstract: The present invention pertains to field of pharmaceutical chemicals, and relates to thiazole inner salt compounds, preparation methods and uses thereof. Specifically, the present invention relates to a compound of Formula I, hydrates or pharmaceutically acceptable salts thereof. The compound of Formula I of the present invention is a potent cross-linking protein cleavage agent, has a stable structure, good physical and chemical properties, and good pharmacological activities, and is suitable for large scale production to obtain samples with stable, controllable and reliable quality, thereby being suitable for pharmaceutical development.Type: GrantFiled: April 12, 2019Date of Patent: November 23, 2021Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. ChinaInventors: Song Li, Wu Zhong, Shuang Cao, Lili Wang, Zhibing Zheng, Junhai Xiao, Xinbo Zhou
-
Patent number: 10989695Abstract: Disclosed are an online monitoring system for a crack on a hoist spindle and an operation method thereof. The system comprises: a rope power part, a crack detection part, a wireless transmission part, and a computer. The rope power part comprises two traction ropes, two guide wheels, two stepper motors, and two stepper motor drivers. The crack detection part comprises a spiral tube guide rail, a sliding body, and an ultrasonic generator. The wireless transmission part comprises three zigbee wireless sensing modules. The zigbee wireless sensing modules receive instructions from the computer and transmit the instructions to the stepper motor drivers to control the motors to rotate. The stepper motors drive the guide wheels to rotate to realize the winding of the ropes, so as to pull the sliding body to slide on the spiral tube guide rail. The ultrasonic generator clamped on the sliding body monitors the rotating spindle along the spiral tube guide rail.Type: GrantFiled: July 1, 2019Date of Patent: April 27, 2021Assignee: China University of Mining and TechnologyInventors: Zhencai Zhu, Hao Lu, Shuang Cao, Yuxing Peng, Gongbo Zhou, Guohua Cao, Gang Shen, Wei Li, Dagang Wang, Fan Jiang
-
Publication number: 20210041402Abstract: Disclosed are an online monitoring system for a crack on a hoist spindle and an operation method thereof. The system comprises: a rope power part, a crack detection part, a wireless transmission part, and a computer. The rope power part comprises two traction ropes, two guide wheels, two stepper motors, and two stepper motor drivers. The crack detection part comprises a spiral tube guide rail, a sliding body, and an ultrasonic generator. The wireless transmission part comprises three zigbee wireless sensing modules. The zigbee wireless sensing modules receive instructions from the computer and transmit the instructions to the stepper motor drivers to control the motors to rotate. The stepper motors drive the guide wheels to rotate to realize the winding of the ropes, so as to pull the sliding body to slide on the spiral tube guide rail. The ultrasonic generator clamped on the sliding body monitors the rotating spindle along the spiral tube guide rail.Type: ApplicationFiled: July 11, 2019Publication date: February 11, 2021Applicant: China University of Mining and TechnologyInventors: Hao LU, Shuang CAO, Zhencai ZHU, Yuxing PENG, Gongbo ZHOU, Guohua CAO, Gang SHEN, Wei LI, Dagang WANG, Fan JIANG
-
Publication number: 20190233383Abstract: The present invention pertains to field of pharmaceutical chemicals, and relates to thiazole inner salt compounds, preparation methods and uses thereof. Specifically, the present invention relates to a compound of Formula I, hydrates or pharmaceutically acceptable salts thereof. The compound of Formula I of the present invention is a potent cross-linking protein cleavage agent, has a stable structure, good physical and chemical properties, and good pharmacological activities, and is suitable for large scale production to obtain samples with stable, controllable and reliable quality, thereby being suitable for pharmaceutical development.Type: ApplicationFiled: April 12, 2019Publication date: August 1, 2019Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. ChinaInventors: Song LI, Wu ZHONG, Shuang CAO, Lili WANG, Zhibing ZHENG, Junhai XIAO, Xinbo ZHOU
-
Patent number: 10160767Abstract: The present invention pertains to the field of pharmaceutical chemicals, and relates to a rapamycin derivative of Formula I, and a preparation method, pharmaceutical composition and use thereof. The compounds of the present invention overcome the defects of rapamycin in terms of water solubility and metabolic properties, and some of the compounds have an in vitro anti-tumor activity superior to rapamycin, have less toxicity to normal cells than rapamycin, and have very good druggability.Type: GrantFiled: June 3, 2015Date of Patent: December 25, 2018Assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. ChinaInventors: Wu Zhong, Song Li, Shuang Cao, Ruiyuan Cao, Junhai Xiao, Xinbo Zhou, Xingzhou Li
-
Publication number: 20170253606Abstract: The present invention pertains to the field of pharmaceutical chemicals, and relates to a rapamycin derivative of Formula I, and a preparation method, pharmaceutical composition and use thereof. The compounds of the present invention overcome the defects of rapamycin in terms of water solubility and metabolic properties, and some of the compounds have an in vitro anti-tumor activity superior to rapamycin, have less toxicity to normal cells than rapamycin, and have very good druggability.Type: ApplicationFiled: June 3, 2015Publication date: September 7, 2017Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. ChinaInventors: Wu ZHONG, Song LI, Shuang CAO, Ruiyuan CAO, Junhai XIAO, Xinbo ZHOU, Xingzhou LI
-
Publication number: 20160137619Abstract: The present invention pertains to field of pharmaceutical chemicals, and relates to thiazole inner salt compounds, preparation methods and uses thereof. Specifically, the present invention relates to a compound of Formula I, hydrates or pharmaceutically acceptable salts thereof. The compound of Formula I of the present invention is a potent cross-linking protein cleavage agent, has a stable structure, good physical and chemical properties, and good pharmacological activities, and is suitable for large scale production to obtain samples with stable, controllable and reliable quality, thereby being suitable for pharmaceutical development.Type: ApplicationFiled: July 9, 2014Publication date: May 19, 2016Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. ChinaInventors: Song LI, Wu ZHONG, Shuang CAO, Lili WANG, Zhibing ZHENG, Junhai XIAO, Xinbo ZHOU